Prospective PuraPly™ AM Case Series Study

CompletedOBSERVATIONAL
Enrollment

43

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

April 30, 2017

Study Completion Date

May 31, 2017

Conditions
Pressure UlcersVenous UlcersDiabetic UlcersSurgical WoundsTrauma Wounds
Interventions
DEVICE

PuraPly™ Antimicrobial Wound Matrix

PuraPly AM consists of a collagen sheet coated with polyhexamethylene biguanide hydrochloride (PHMB) intended for the management of wounds. PuraPly AM is supplied dry in sheet form. The device is packaged in sterile, sealed single patches.

Trial Locations (1)

11402

Northwell Health, Inc, Lake Success

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Organogenesis

INDUSTRY

NCT03070925 - Prospective PuraPly™ AM Case Series Study | Biotech Hunter | Biotech Hunter